RxDoctor Payments Data

Radmila Samardzija, DPM

Foot & Ankle Surgery · Kansas City, KSNPI 1053557199

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations.

$4,893in general payments, 2019–2025

Across 136 payments — averaging $35.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$873
  • Kerecis Limited$619
  • Organogenesis Inc.$559
  • Stryker$295
  • Paratek Pharmaceuticals, Inc.$277
  • Smith+Nephew$166
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$4,893100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,893 in reported general payments places this provider in the 55th percentile of 40 foot & ankle surgery providers in Kansas.

See all foot & ankle surgery providers in Kansas

Medicare billing

Part B allowed, 2024
$73,822
Medicare patients
334
Services billed
1,125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox75$2,971
Gabapentin43$511
Terbinafine Hcl13$330
Methylprednisolone17$125
Doxycycline Hyclate11$77
Triamcinolone Acetonide11$45

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Kansas City

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →